Literature DB >> 10432494

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.

P Blier1, C de Montigny.   

Abstract

The therapeutic effectiveness of antidepressant drugs in major depression was discovered by pure serendipity. It took over 20 years before the neurobiological modifications that could mediate the antidepressive response were put into evidence. Indeed, whereas the immediate biochemical effects of these drugs had been well documented, their antidepressant action generally does not become apparent before 2 to 3 weeks of treatment. The different classes of antidepressant treatments were subsequently shown to enhance serotonin neurotransmission albeit via different pre- and postsynaptic mechanisms. Clinical trials based on this hypothesis led to the development of treatment strategies producing greater efficacy and more rapid onset of antidepressant action; that, is lithium addition and pindolol combination, respectively. It is expected that the better understanding recently obtained of the mechanism of action of certain antidepressant drugs in obsessive-compulsive and panic disorders will also lead to more effective treatment strategies for those disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432494     DOI: 10.1016/S0893-133X(99)00036-6

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  58 in total

Review 1.  Amine neurochemistry and aggression in crayfish.

Authors:  Jules B Panksepp; Zhaoxia Yue; Catherine Drerup; Robert Huber
Journal:  Microsc Res Tech       Date:  2003-02-15       Impact factor: 2.769

2.  Environmental enrichment reverses the effects of maternal separation on stress reactivity.

Authors:  Darlene D Francis; Josie Diorio; Paul M Plotsky; Michael J Meaney
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior.

Authors:  P V Strong; J P Christianson; A B Loughridge; J Amat; S F Maier; M Fleshner; B N Greenwood
Journal:  Neuroscience       Date:  2011-09-24       Impact factor: 3.590

4.  Chronic fluoxetine treatment changes S100B expression during postnatal rat brain development.

Authors:  Nathalie Bock; Emre Koc; Hannah Alter; Veit Roessner; Andreas Becker; Aribert Rothenberger; Till Manzke
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-09-11       Impact factor: 2.576

Review 5.  Vagus nerve stimulation (VNS) for depression: what do we know now and what should be done next?

Authors:  Ziad Nahas; Carol Burns; Milton J Foust; Baron Short; Tal Herbsman; Mark S George
Journal:  Curr Psychiatry Rep       Date:  2006-12       Impact factor: 5.285

Review 6.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

7.  Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex.

Authors:  Francis Rodriguez Bambico; Noam Katz; Guy Debonnel; Gabriella Gobbi
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

8.  The effects of fluoxetine and its complexes with glycerrhizic acid on behavior in rats and brain monoamine levels.

Authors:  G T Shishkina; N N Dygalo; A M Yudina; T S Kalinina; T G Tolstikova; I V Sorokina; I L Kovalenko; L V Anikina
Journal:  Neurosci Behav Physiol       Date:  2006-05

9.  Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors).

Authors:  M Riad; K C Watkins; E Doucet; M Hamon; L Descarries
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

10.  Lack of association between the serotonin transporter and serotonin 1A receptor: an in vivo PET imaging study in healthy adults.

Authors:  Michael Strupp-Levitsky; Jeffrey M Miller; Harry Rubin-Falcone; Francesca Zanderigo; Matthew S Milak; Gregory Sullivan; R Todd Ogden; Maria A Oquendo; Christine DeLorenzo; Norman Simpson; Ramin V Parsey; J John Mann
Journal:  Psychiatry Res Neuroimaging       Date:  2016-08-08       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.